Histamine, Type I Hypersensitivity and Anti-histamines
Histamine, Type I Hypersensitivity and Anti-histamines
Instructor: Vanishree Rajagopalan, PhD
Email: vrajagop@touro.edu
Course Code: PRMC 646
Learning Objectives and Study Guide
Refer to course materials on Canvas for comprehensive learning objectives and study guide.
Lecture Overview
Topics Covered
Histamine
Synthesis and degradation
Location and physiology
Pharmacology: receptors and signaling
Pathophysiology in IgE mediated hypersensitivity
Antihistamines
H1 antagonists
H2 antagonists (details next semester)
Physiological antagonists
Prevention of histamine release
Side Effects and Clinical Uses
Histamine: Synthesis and Degradation
Definition
Histamine is a biogenic amine and an autacoid.
Major mediator of the inflammatory process.
Regulates gastric acid secretion.
Plays a minor role in neurotransmission.
Found in various tissues including:
Lungs
Vasculature
Stomach
Central Nervous System (CNS)
Peripheral nerves
Synthesis
Synthesized in:
Mast cells
Basophils
ECL cells (enterochromaffin-like cells) in gastric mucosa
CNS
Histamine is stored in granules, with two pools:
Slow-turning over pool: Basophils and mast cells (replenished slowly)
Rapidly turning over pool: ECL cells and neurons (not stored; synthesized on demand)
Reference: Golan, Ch. 42
Histamine: Location and Physiology
Location
Primarily located in:
Mast cells and basophils
Lungs, skin, gastrointestinal tract (GIT) - areas where the inside meets the outside
Found in venoms and insect stings
Release Mechanism
Released following antigen presentation from:
Colds
Bacterial toxins
Bee sting venoms
Trauma
Allergies
Anaphylaxis through IgE sensitization of mast cells (immediate, type 1 allergic reaction)
Physiological Effects
Histamine release mediates symptoms of:
Allergic rhinitis (hay fever)
Acute urticaria (hives)
Major mediator of Type I hypersensitivity response, particularly in seasonal allergies.
Flush-Flare-Wheal Reaction
Flush: Dilation of blood vessels results in local redness (erythema).
Widespread dilation may decrease vascular resistance, leading to lower blood pressure and shock.
Flare: Stimulation of sensory nerve endings results in itching and pain in the skin.
Wheal: Increased capillary permeability from vascular endothelium contraction results in tissue swelling (edema).
Widespread effects can lead to decreased blood volume and shock.
Tissue-Specific Effects
Lungs/Bronchi: Bronchoconstriction which may lead to asthma-like symptoms (H1 receptor)
Vascular Smooth Muscle: Dilation (Flush) and venoconstriction (H1 receptor)
Vascular Endothelium: Contraction leads to edema (Wheal) (H1 receptor)
Peripheral Nerves: Sensitization of afferent nerve terminals causing itchiness and pain (H1, H4 receptors)
Heart: Minor increase in heart rate and contraction (H2 receptor)
Stomach: Increased gastric acid secretion contributing to peptic ulcer disease (PUD) and heartburn (H2 receptor)
CNS: Acts as a neurotransmitter affecting circadian rhythms and wakefulness (H3 receptor)
Histamine in IgE-Mediated Hypersensitivity
Role of Histamine
Histamine is the major mediator in Type I/IgE-mediated hypersensitivity evidenced by:
Primary response: Mast cell degranulation upon initial allergen exposure
Secondary response: Effects from basophils and eosinophils
Symptoms Resulting from Histamine Release
Flush, flare, and wheal reactions in skin
Symptoms include runny nose, itchy eyes, and nasal congestion
Anaphylaxis characterized by systemic vasodilation and severe bronchoconstriction
Mast Cell Degranulation
Mast cells are located in tissues exposed to the outside environment:
Skin, connective tissues, eyes, nasal passages, lungs, digestive system
Positioned near small blood vessels and postcapillary venules
Pathophysiology of IgE-Mediated Hypersensitivity
Mechanism
Initial exposure to an allergen leads to sensitization of B cells and production of IgE.
Subsequent exposure: allergen cross-links IgE antibodies on mast cells, triggering degranulation and releasing histamine, resulting in associated symptoms.
Anaphylaxis Mechanism
Induced by systemic mast cell degranulation in individuals previously sensitized to allergens such as:
Allergenic food (e.g., nuts)
Insect bites
Antibiotics (e.g., penicillin)
Effects include:
Systemic vasodilation
Massive hypotension
Severe bronchoconstriction
Potentially lethal if not treated immediately
Symptomatic Treatment Strategies
Epinephrine:
Administered for severe systemic anaphylactic reactions
Mechanism: Relaxes bronchial smooth muscle, constricts blood vessels, stimulates heart activity
Antihistamines:f
Block histamine from binding to its receptors on target cells, act as inverse agonists.
Steroids:
Corticosteroids serve as potent anti-inflammatory agents, applied topically or taken orally.
Sodium cromolyn:
Prevents mast cell degranulation and subsequent histamine release.
Histamine Receptor Pharmacology
Receptor Subtypes
H1:
Signaling mechanism: Gq/11 → Increased IP3, DAG, and intracellular Ca2+; activates NF-κB.
Tissue distribution: Smooth muscle, vascular endothelium, brain (autoreceptor).
H2:
Signaling mechanism: Gs → Increased cAMP.
Tissue distribution: Gastric parietal cells, cardiac muscle, mast cells, brain.
H3:
Signaling mechanism: Gi/o → Decreased cAMP.
Tissue distribution: CNS and select peripheral nerves.
H4:
Signaling mechanism: Gi/o → Decreased cAMP, increased intracellular Ca2+.
Tissue distribution: Hematopoietic cells, gastric mucosa.
Antihistamines
H1-Antihistamines
Classification
First Generation:
Chlorpheniramine
Diphenhydramine
Meclizine
Second Generation:
Loratadine
Cetirizine
Fexofenadine
Mechanism of Action
Historically referred to as H1 receptor competitive antagonists but more recently shown to be inverse agonists.
CNS Effects
First Generation H1-Antihistamines can cross the blood-brain barrier (BBB), leading to central nervous system (CNS) effects.
Side effects include sedation due to blockade of both H1 and M receptors.
Second Generation H1-Antihistamines
Do not cross BBB, thus have no CNS effects.
Additional Effects
Antiemetic (dopaminergic): Doxylamine
Anticholinergic: Side effects include urinary retention, dry mouth, constipation, blurred vision
Antiadrenergic: Example: Promethazine - causes hypotension.
Serotonin blockade: Example: Cyproheptadine.
Local Anesthesia: Example: Diphenhydramine can block Na channels in excitable membranes.
Therapeutic Uses
Allergic conditions:
Used for allergic rhinitis and urticaria.
Common medications: chlorpheniramine, meclizine, diphenhydramine (first generations) and fexofenadine, loratadine (second generations).
Motion sickness and nausea:
Prevents or diminishes nausea primarily through vestibular pathways.
Example medications: dimenhydrinate, doxylamine.
Somnificants/Sedatives:
Due to interaction with other receptors.
Example: Diphenhydramine.
Adverse Effects
Side effects are related to interactions with other receptors:
Antimuscarinic effects: Dry mouth, blurred vision, constipation.
Alpha adrenoceptor blocking effects: Orthostatic hypotension.
Review Questions
Histamine H1 receptor blockers are useful in the treatment of which of the following?
a. urticaria
b. seasonal rhinitis
c. asthma
d. a and b
Which of the following drugs can reverse one or more smooth muscle effects of large increases in circulating histamine resulting from anaphylaxis in humans?
a. chlorpheniramine
b. cimetidine
c. epinephrine
d. sumatriptan
e. none of the above
A 22-year-old female student asks for a recommendation for sneezing, watery and itchy eyes, and runny nose. What would be the best recommendation?
a. cromolyn sodium
b. fexofenadine
c. cimetidine
d. diphenhydramine
Of the following antihistamines, which one is used for the purpose of sedation?
a. loratadine
b. cetirizine
c. cimetidine
d. diphenhydramine